Twist Bioscience Corp TWST
Twist Bioscience Corp statistics & valuation
Market cap$6.2B
P / S16.5×
P / B13.1×
Net margin-20.6%
Return on equity-16.4%
FCF margin-20.1%
Return on capital-24.8%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | -36.2% | -70.6% | -88.6% | -115.3% | -115.4% | -155.5% | -200.1% | -277.5% |
| Net margin | -20.6% | -66.7% | -83.5% | -107.0% | -114.9% | -155.3% | -198.0% | -280.2% |
| FCF margin | -20.1% | -22.1% | -69.5% | -111.1% | -105.3% | -168.8% | -188.8% | -274.7% |
| Return on assets | -12.1% | -34.0% | -26.4% | -22.7% | -21.7% | -35.1% | -57.6% | -61.5% |
| Return on equity | -16.4% | -44.2% | -32.8% | -27.6% | -26.2% | -41.6% | -70.8% | 35.4% |
| Debt / equity | — | — | — | — | — | 0.01× | 0.05× | -0.04× |
| Current ratio | 3.64 | 4.88 | 5.79 | 6.58 | 8.67 | 9.29 | 5.28 | 5.16 |
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.